Community Action Needed: Please respond to the NIH RFI
TALEN

TALEN1-f2

ID
ZDB-TALEN-200818-1
Name
TALEN1-f2
Previous Names
None
Target
Target Sequence 1
5' - TTTAATGTGACACAGCTG - 3'
Target Sequence 2
5' - TATCTGGGTTCCTGCAGA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
mi4008 f2
Expression
Gene expression in Wild Types + TALEN1-f2
No data available
Phenotype
Phenotype resulting from TALEN1-f2
No data available
Phenotype of all Fish created by or utilizing TALEN1-f2
Phenotype Fish Conditions Figures
brain hemorrhagic, abnormal f2mi4008/mi4008(AB/TL) standard conditions Figure 5 with image from Grzegorski et al., 2020
posterior cardinal vein blood coagulation, fibrin clot formation delayed, abnormal f2mi4008/mi4008(AB/TL) light damage: posterior cardinal vein, chemical treatment by environment: 6-aminohexanoic acid Figure 6 with image from Grzegorski et al., 2020
whole organism hemorrhagic, abnormal f2mi4008/mi4008(AB/TL) standard conditions Figure 5 with image from Grzegorski et al., 2020
whole organism f2 expression decreased amount, abnormal f2mi4008/mi4008(AB/TL) standard conditions Figure 3 with image from Grzegorski et al., 2020
posterior cardinal vein blood coagulation, fibrin clot formation delayed, abnormal f2mi4008/mi4008(AB/TL) light damage: posterior cardinal vein Figure 6 with image from Grzegorski et al., 2020
whole organism decreased life span, abnormal f2mi4008/mi4008(AB/TL) standard conditions Figure 5 with image from Grzegorski et al., 2020
blood coagulation process quality, abnormal f2mi4008/mi4008(AB/TL) light damage: posterior cardinal vein Figure 6 with image from Grzegorski et al., 2020
liver f2 expression decreased amount, abnormal f2mi4008/mi4008(AB/TL) standard conditions Figure 3 with image from Grzegorski et al., 2020
blood coagulation process quality, abnormal f2mi4008/mi4008(AB/TL) light damage: posterior cardinal vein, chemical treatment by environment: 6-aminohexanoic acid Figure 6 with image from Grzegorski et al., 2020
blood coagulation process quality, abnormal f2mi4008/mi4008; la2Tg(AB/TL) light damage: dorsal aorta Figure 6 with image from Grzegorski et al., 2020
dorsal aorta blood coagulation, fibrin clot formation delayed, abnormal f2mi4008/mi4008; la2Tg(AB/TL) light damage: dorsal aorta Figure 6 with image from Grzegorski et al., 2020
Citations